2024-02-14 15:36:06 ET
Amgen Inc. (AMGN)
Oppenheimer 34th Annual Healthcare Life Sciences Conference
February 14, 2024 12:00 PM ET
Company Participants
Justin Claeys - Vice President of Finance and Treasurer
Murdo Gordon - Executive Vice President of Global Commercial Operations
James Bradner - EVP of Research and Development and Chief Scientific Officer
Justin Claeys - Vice President of Finance and Treasurer
Conference Call Participants
Jay Olson - Oppenheimer & Co
Presentation
Jay Olson
Hello, everyone, and welcome to Oppenheimer’s 34th Annual Healthcare Conference. I’m Jay Olson, one of the biotech analysts at Oppenheimer. Thank you all for joining us here today.
It is my pleasure to welcome Amgen to our conference, and it is an honor to introduce Justin Claeys, Head of IR; Susan Sweeney, Head of Global Marketing Access and Capabilities; Murdo Gordon, Head of Global Commercial Operations; and Jay Bradner, Head of R&D.
So we have an amazing lineup here today. And it is great to see all of you and really appreciate you making time for us today. Thank you so much.
Justin Claeys
Great. Thank you, Jay. We are really glad to be here today. It is an exciting time at Amgen, and we appreciate the chance to share why we are so optimistic about our growth potential.
We see many opportunities across our 4 therapeutic area pillars: General Medicine, Oncology, Inflammation and Rare Disease. We have a long track record of successfully executing, and that gives us confidence that we will continue to deliver. Our mission is to serve patients, and we have never been better positioned to do so....
Read the full article on Seeking Alpha
For further details see:
Amgen Inc. (AMGN) Oppenheimer 34th Annual Healthcare Life Sciences Conference (Transcript)